Wells Fargo & Company Brainstorm Cell Therapeutics Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 52,777 shares of BCLI stock, worth $120,331. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,777
Previous 28,811 83.18%
Holding current value
$120,331
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.22 - $0.42 $5,272 - $10,065
23,966 Added 83.18%
52,777 $12,000
Q2 2024

Aug 13, 2024
SELL
$0.34 - $0.74 $101 - $221
-299 Reduced 1.03%
28,811 $9,000
Q1 2024

May 10, 2024
SELL
$0.28 - $0.66 $216 - $509
-772 Reduced 2.58%
29,110 $16,000
Q4 2023

Feb 09, 2024
SELL
$0.15 - $0.4 $1,574 - $4,198
-10,495 Reduced 25.99%
29,882 $8,000
Q3 2023

Nov 13, 2023
BUY
$0.2 - $2.08 $604 - $6,287
3,023 Added 8.09%
40,377 $8,000
Q2 2023

Aug 15, 2023
BUY
$2.0 - $3.2 $25,092 - $40,147
12,546 Added 50.57%
37,354 $76,000
Q1 2023

May 12, 2023
BUY
$1.43 - $3.3 $7,059 - $16,292
4,937 Added 24.85%
24,808 $81,000
Q4 2022

Feb 13, 2023
SELL
$1.37 - $4.42 $701 - $2,263
-512 Reduced 2.51%
19,871 $32,000
Q3 2022

Nov 14, 2022
BUY
$2.55 - $4.42 $6,339 - $10,988
2,486 Added 13.89%
20,383 $90,000
Q2 2022

Aug 12, 2022
BUY
$2.71 - $3.6 $4,531 - $6,019
1,672 Added 10.31%
17,897 $50,000
Q1 2022

May 16, 2022
SELL
$2.92 - $4.19 $6,812 - $9,775
-2,333 Reduced 12.57%
16,225 $55,000
Q4 2021

Feb 14, 2022
BUY
$2.81 - $4.23 $15,106 - $22,740
5,376 Added 40.78%
18,558 $74,000
Q3 2021

Nov 15, 2021
BUY
$3.14 - $4.09 $1,180 - $1,537
376 Added 2.94%
13,182 $44,000
Q2 2021

Aug 16, 2021
SELL
$3.01 - $4.01 $53,463 - $71,225
-17,762 Reduced 58.11%
12,806 $49,000
Q1 2021

May 13, 2021
SELL
$3.46 - $7.88 $249,472 - $568,163
-72,102 Reduced 70.23%
30,568 $116,000
Q4 2020

Feb 09, 2021
BUY
$3.99 - $17.73 $140,364 - $623,723
35,179 Added 52.12%
102,670 $465,000
Q3 2020

Nov 05, 2020
BUY
$11.19 - $16.92 $91,299 - $138,050
8,159 Added 13.75%
67,491 $1.14 Million
Q2 2020

Aug 13, 2020
BUY
$4.42 - $12.66 $193,282 - $553,609
43,729 Added 280.26%
59,332 $665,000
Q1 2020

May 14, 2020
BUY
$4.01 - $8.88 $62,568 - $138,554
15,603 New
15,603 $73,000

Others Institutions Holding BCLI

# of Institutions
41
Shares Held
10.8M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $83.2M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email